Shantha Biotechnics Limited manufactures Recombinant Human Erythropoietin. Shantha Biotechnics Limited offers recombinant DNA vaccines and human healthcare products. The Recombinant Human Erythropoietin is a glycoprotein produced in mammalian cells by inserting the gene coding for human erythropoietin. Erythropoietin is used in the treatment of anaemia. Treatment with Erythropoietin results in improvement in haemoglobin levels thereby improving the quality of life in patients with chronic renal failure, cancer patients on chemotherapy, surgery patients and patients with HIV related anaemia.